Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/news/2023/04/13/3-stocks-making-outsized-moves-today

4/13/2023 2:59 PM

Stocks are bouncing in the wake of the latest encouraging inflation reading. Three names making notable moves include Delta Air Lines Inc (NYSE:DAL), biotech stock Crispr Therapeutics AG (NASDAQ:CRSP...

3 Biotech Stocks to Watch Heading Into 2023

https://www.schaeffersresearch.com/content/options/2022/12/29/3-biotech-stocks-to-watch-heading-into-2023

12/29/2022 2:49 PM

Pharma and biotech stocks are enjoying tailwinds as part of the broad market rally today. Biogen Inc (NASDAQ:BIIB), Crispr Therapeutics AG (NASDAQ:CRSP), and also Vertex Pharmaceuticals Incorporated ...

Biotech Stock Could Be Headed Toward New Record Highs

https://www.schaeffersresearch.com/content/analysis/2020/10/13/biotech-stock-could-be-headed-toward-new-record-highs

10/13/2020 3:34 PM

The shares of Crispr Therapeutics (NASDAQ:CRSP) are up 0.8% to trade at $100.24 at last check. And while the pharmaceutical stock has cooled off from its all-time-high of $105.12 on Aug. 19, it has s...

Strong First Week of August Marred by Stimulus, China Tensions

https://www.schaeffersresearch.com/content/news/2020/08/07/strong-first-week-of-august-marred-by-stimulus-china-tensions

8/7/2020 1:28 PM

Volatile sentiment surrounding the stalled second stimulus bill in congress permeated through the market this week, as investors listened for cues as to whether the stiff negotiations would soon be...

Bullish Signal Could Mean New Heights for Gene Therapy Stock

https://www.schaeffersresearch.com/content/options/2020/08/05/bullish-signal-could-mean-new-heights-for-gene-therapy-stock

8/5/2020 2:52 PM

The shares of Crispr Therapeutics AG ( NASDAQ: CRSP) are down 1.2% to trade at $93.47 this afternoon, though the stock still enjoys a 97.8% year-over-year lead, with support from its the 30-day moving...

PEOPLE ALSO SEARCH FOR